Conversely, expression of the inhibitory receptor CD200R on B cells (CD19+CD200R+) was significantly reduced in both patient groups relative to HV (p < 0.001), with CVID showing the lowest levels (p = 0.0489 vs. CLL with SID; Figure 1C). Here, CD19 is linked to B-cell chronic lymphocytic leukemia.